These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 24976018

  • 1. Red blood cells serve as intravascular carriers of myeloperoxidase.
    Adam M, Gajdova S, Kolarova H, Kubala L, Lau D, Geisler A, Ravekes T, Rudolph V, Tsao PS, Blankenberg S, Baldus S, Klinke A.
    J Mol Cell Cardiol; 2014 Sep; 74():353-63. PubMed ID: 24976018
    [Abstract] [Full Text] [Related]

  • 2. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
    Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szöcs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T.
    Circulation; 2006 Apr 18; 113(15):1871-8. PubMed ID: 16606792
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Binding of human myeloperoxidase to red blood cells: Molecular targets and biophysical consequences at the plasma membrane level.
    Gorudko IV, Sokolov AV, Shamova EV, Grigorieva DV, Mironova EV, Kudryavtsev IV, Gusev SA, Gusev AA, Chekanov AV, Vasilyev VB, Cherenkevich SN, Panasenko OM, Timoshenko AV.
    Arch Biochem Biophys; 2016 Feb 01; 591():87-97. PubMed ID: 26714302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients.
    Di Pietro N, Giardinelli A, Sirolli V, Riganti C, Di Tomo P, Gazzano E, Di Silvestre S, Panknin C, Cortese-Krott MM, Csonka C, Kelm M, Ferdinandy P, Bonomini M, Pandolfi A.
    Mol Cell Biochem; 2016 Jun 01; 417(1-2):155-67. PubMed ID: 27206740
    [Abstract] [Full Text] [Related]

  • 8. Leukocyte-derived myeloperoxidase amplifies high-glucose--induced endothelial dysfunction through interaction with high-glucose--stimulated, vascular non--leukocyte-derived reactive oxygen species.
    Zhang C, Yang J, Jennings LK.
    Diabetes; 2004 Nov 01; 53(11):2950-9. PubMed ID: 15504976
    [Abstract] [Full Text] [Related]

  • 9. A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome.
    Benson TW, Weintraub NL, Kim HW, Seigler N, Kumar S, Pye J, Horimatsu T, Pellenberg R, Stepp DW, Lucas R, Bogdanov VY, Litwin SE, Brittain JE, Harris RA.
    Lab Invest; 2018 Oct 01; 98(10):1300-1310. PubMed ID: 29572498
    [Abstract] [Full Text] [Related]

  • 10. Myeloperoxidase, a leukocyte-derived vascular NO oxidase.
    Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA.
    Science; 2002 Jun 28; 296(5577):2391-4. PubMed ID: 12089442
    [Abstract] [Full Text] [Related]

  • 11. Myeloperoxidase upregulates endothelin receptor type B expression.
    Lau D, Szöcs K, Klinke A, Rudolph T, Rudolph V, Streichert T, Blankenberg S, Baldus S.
    J Mol Cell Cardiol; 2014 Apr 28; 69():76-82. PubMed ID: 24417960
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Variable adhesion of different red blood cell products to activated vascular endothelium under flow conditions.
    Anniss AM, Sparrow RL.
    Am J Hematol; 2007 Jun 28; 82(6):439-45. PubMed ID: 17133424
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
    Marshall CJ, Nallaratnam M, Mocatta T, Smyth D, Richards M, Elliott JM, Blake J, Winterbourn CC, Kettle AJ, McClean DR.
    Am J Cardiol; 2010 Aug 01; 106(3):316-22. PubMed ID: 20643239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure.
    Datta B, Tufnell-Barrett T, Bleasdale RA, Jones CJ, Beeton I, Paul V, Frenneaux M, James P.
    Circulation; 2004 Mar 23; 109(11):1339-42. PubMed ID: 15023874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Myeloperoxidase and its contributory role in inflammatory vascular disease.
    Lau D, Baldus S.
    Pharmacol Ther; 2006 Jul 23; 111(1):16-26. PubMed ID: 16476484
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.